Submitted by Anonymous (not verified) on 8 February 2024 - 13:08
Orphan designation: Selumetinib Treatment of amyotrophic lateral sclerosis, 13/12/2023 Positive
Source:
Orphan designation: Selumetinib Treatment of amyotrophic lateral sclerosis, 13/12/2023 Positive